| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200003163421102 |
| P698 | PubMed publication ID | 10717010 |
| P50 | author | Marc A. Judson | Q38803534 |
| Thomas Platts-Mills | Q7793186 | ||
| P2093 | author name string | Lee JY | |
| Stevens DA | |||
| Schwartz HJ | |||
| Weinmann AJ | |||
| Tuazon CU | |||
| DeGraff AC Jr | |||
| Moskovitz BL | |||
| Catanzaro A | |||
| Bamberger DM | |||
| Jerome DC | |||
| P2860 | cites work | Treatment of invasive aspergillosis with itraconazole | Q46380526 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| randomized experiment | Q1231081 | ||
| allergic bronchopulmonary aspergillosis | Q1430844 | ||
| P304 | page(s) | 756-762 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis | |
| P2283 | uses | randomized experiment | Q1231081 |
| P478 | volume | 342 |
| Q90254018 | A Prospective Real-World Study of the Impact of an Antifungal Stewardship Program in a Tertiary Respiratory-Medicine Setting |
| Q50282156 | A case of allergic bronchopulmonary aspergillosis in a 43-year-old farmer following single high level exposure to organic dust with symptomatic remission and radiological resolution after early diagnosis and treatment. |
| Q36388027 | A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients |
| Q51606924 | A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis. |
| Q58811338 | Acute Exacerbations of Airway Inflammation |
| Q36968480 | Advances in management of paranasal sinus aspergillosis |
| Q35543734 | Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
| Q87631539 | Allergic Bronchopulmonary Aspergillosis |
| Q74574635 | Allergic bronchopulmonary aspergillosis |
| Q44216201 | Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin |
| Q37878272 | Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis |
| Q39319765 | Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues |
| Q59812079 | Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature |
| Q38256151 | Allergic bronchopulmonary aspergillosis: A clinical review of 24 patients: Are we right in frequent serologic monitoring? |
| Q34719251 | Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution |
| Q34192961 | Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment |
| Q38079263 | Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview |
| Q79870478 | Allergic fungal sinusitis |
| Q46755690 | Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity? |
| Q35669827 | Allergic fungal sinusitis: pathogenesis and management strategies |
| Q54948318 | An algorithmic approach for the treatment of severe uncontrolled asthma. |
| Q54394711 | An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. |
| Q37723371 | An unusual cause of lung mass in a young female |
| Q74556699 | An unusual etiology of persistent cough in an 8-year-old girl with cystic fibrosis |
| Q38484090 | Antibody testing in aspergillosis--quo vadis? |
| Q57689804 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis |
| Q24187765 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis |
| Q24202783 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis |
| Q73385866 | Antifungal therapy for allergic bronchopulmonary aspergillosis |
| Q38210276 | Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. |
| Q38948097 | Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions? |
| Q44800591 | Aspergillosis in cystic fibrosis patients |
| Q35038459 | Aspergillosis. Pathogenesis, clinical manifestations, and therapy |
| Q35045054 | Aspergillus fumigatus and related species |
| Q33719294 | Aspergillus infections in transplant recipients |
| Q37077782 | Aspergillus-associated airway disease, inflammation, and the innate immune response |
| Q41441699 | Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging. |
| Q57416135 | Asthma |
| Q37776805 | Asthma in the elderly: Diagnosis and management |
| Q47850725 | Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern? |
| Q24246695 | Azoles for allergic bronchopulmonary aspergillosis associated with asthma |
| Q24250156 | Azoles for allergic bronchopulmonary aspergillosis associated with asthma |
| Q30243947 | Bronchiectasis and Aspergillus: How are they linked? |
| Q38221676 | Burden and distinctive character of allergic bronchopulmonary aspergillosis in India |
| Q46837585 | Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole |
| Q36655481 | Central airways obstruction due to Aspergillus fumigatus after lung transplantation |
| Q35561667 | Chemokines and cytokines: axis and allies in asthma and allergy |
| Q38168300 | Chronic pulmonary aspergillosis. |
| Q34546811 | Clinical hepatotoxicity associated with antifungal agents |
| Q93386994 | Daily dose of itraconazole 100 mg to treat allergic bronchopulmonary aspergillosis (ABPA) related eosinophilia: a case report |
| Q28196300 | Differential diagnosis of eosinophilic chronic rhinosinusitis |
| Q61895241 | Difficult asthma |
| Q34169948 | Effectiveness of itraconazole on clinical symptoms and radiologic findings in patients with recurrent chronic rhinosinusitis and nasal polyposis |
| Q40334448 | Eosinophilic pleural effusion complicating allergic bronchopulmonary aspergillosis. |
| Q87407558 | Eosinophilic pneumonias |
| Q36149065 | Eosinophilic pneumonias |
| Q38682850 | Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment |
| Q30355164 | Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis. |
| Q40558083 | Fever, abdominal pain, and interstitial pneumonia in a 13-year-old female |
| Q22001138 | Fungal allergy in asthma-state of the art and research needs |
| Q35879450 | Fungal hypersensitivity: pathophysiology, diagnosis, therapy |
| Q34561661 | Fungal rhinosinusitis: diagnosis and therapy |
| Q38124365 | Fungal rhinosinusitis: what every allergist should know |
| Q53341453 | Fungal sensitization in childhood persistent asthma is associated with disease severity. |
| Q38167038 | Fungi: the neglected allergenic sources |
| Q24628838 | High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease |
| Q40123581 | Idiopathic bronchocentric granulomatosis in an asthmatic adolescent |
| Q30276662 | IgE in the diagnosis and treatment of allergic disease |
| Q34535033 | IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. |
| Q37992771 | Impact of Aspergillus fumigatus in allergic airway diseases |
| Q38110850 | Invasive candidiasis: update on current pharmacotherapy options and future perspectives |
| Q44066338 | Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis |
| Q38103889 | Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections |
| Q51573004 | Lassoing a chimera: the semantics of allergic fungal airway disease. |
| Q89912162 | Long-term effect of antifungal therapy for the treatment of severe resistant asthma: an active comparator clinical trial |
| Q58712643 | Lung colonization by Aspergillus fumigatus is controlled by ZNF77 |
| Q28265740 | Management of allergic bronchopulmonary aspergillosis: a review and update |
| Q44924204 | Measured Immunoglobulin E in Allergic Bronchopulmonary Aspergillosis Treated With Omalizumab |
| Q34318533 | Nasal-pulmonary relations in allergic fungal sinusitis and allergic bronchopulmonary aspergillosis |
| Q56837353 | Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses |
| Q46576615 | New agents for the treatment of systemic fungal infections--current status. |
| Q34419666 | Nonresolving pneumonia and mimics of pneumonia. |
| Q61479586 | Normativa del diagnóstico y el tratamiento de la afección respiratoria en la fibrosis quística |
| Q51770958 | Off-label use of omalizumab in non-asthma conditions: new opportunities. |
| Q48327169 | Opportunist Turns Allergen: Double Life of Pneumocystis jirovecii in Asthma |
| Q46819438 | Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients |
| Q37979762 | Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review |
| Q37731037 | Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract |
| Q35557791 | Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis |
| Q40099220 | Pharmacokinetics of Azole Antifungals in Cystic Fibrosis |
| Q37424179 | Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents |
| Q37013047 | Pharmacotherapy for bronchiectasis |
| Q38062584 | Phenotyping airways disease: an A to E approach. |
| Q34977170 | Potential contribution of fungal infection and colonization to the development of allergy |
| Q34532546 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America |
| Q33894472 | Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America |
| Q37701190 | Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India |
| Q97427835 | Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment |
| Q36470394 | Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi. |
| Q46299846 | Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study |
| Q34335236 | Rationale for combination antifungal therapy |
| Q35183728 | Recommendations for the treatment of fungal pneumonias |
| Q42930511 | Reply to "implications of high antifungal susceptibility on Schizophyllum commune-associated allergy in clinical practice". |
| Q33836310 | Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology |
| Q38211509 | Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature. |
| Q26770387 | Serological diagnosis of allergic bronchopulmonary mycosis: Progress and challenges |
| Q35566002 | Severe Asthma |
| Q37976476 | Severe asthma: from characteristics to phenotypes to endotypes |
| Q35625670 | Severe bronchiectasis |
| Q35566009 | Severe rhinosinusitis |
| Q33641883 | Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the Literature |
| Q64914559 | Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection. |
| Q51191763 | The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. |
| Q39444008 | The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. |
| Q30419500 | The role of allergy in severe asthma |
| Q37860762 | The role of anti-infectives in the treatment of refractory asthma |
| Q38699838 | The spectrum of allergic fungal diseases of the upper and lower airways |
| Q37348221 | Toward a comprehensive understanding of allergic lung disease. |
| Q91586137 | Treatment of allergic bronchopulmonary mycosis: Experience of 55 patients with 124 relapses-A descriptive study |
| Q35814394 | Treatment of paediatric non-cystic fibrosis bronchiectasis |
| Q37964703 | Triazole antifungal agents in invasive fungal infections: a comparative review |
| Q92311460 | Two Cases of Allergic Fungal Sinusitis with Differing Postoperative Course |
| Q33691443 | Uncontrolled asthma and recurring pulmonary opacities: just asthma? |
| Q43765277 | Update in pneumology |
| Q41604057 | Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis |
| Q57749749 | What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization |
| Q83129283 | [Allergic broncho-pulmonary aspergillosis treated with voriconazole] |
| Q82487962 | [Allergy-related hypereosinophilia] |
| Q76402196 | [Aspergillus and the lung] |
| Q84789332 | [Asthma and its differential diagnoses] |
| Q81522995 | [Complex respiratory aspergillosis: diagnostic and therapeuthic difficulties] |
| Q51175130 | [Fungal infections in cystic fibrosis]. |
| Q84582191 | [Pulmonary allergic reactions] |
Search more.